Back to Investors
IC

Isomer Capital

Venture Capital

Portfolio

2

companies


Portfolio companies

Encord

Encord

Encord builds AI native data infrastructure designed for physical artificial intelligence systems.

Automata

Automata

Automata builds modular laboratory automation platforms for the life sciences sector.


Recent investments

Series C
£44.3M

Wellington Management led the financing round, which brings total funding to £110m.

"Everyone is focused on building bigger models, but for physical AI, the bottleneck isn't model size. It's data readiness. You can have the most sophisticated model in the world, and it will still fail if the data feeding it is incomplete, inconsistent, or misaligned with real-world conditions. That's the problem we solve."
— Ulrik Stig Hansen, Co-Founder and Co-CEO
£33.1M

Dimension led the funding round, with participation from A.P. Moller Holding and several returning investors.

"The last two years have been hugely exciting at Automata as we’ve seen LINQ increase the scale of customer workflows as well as meaningfully increasing their ability to generate high quality data – accelerating their pace of discovery and experimentation."
— Mostafa Elsayed, Founder and CEO
Series B
£36.7M

The investment round was led by Octopus Ventures with participation from multiple returning and strategic backers.

"Automata’s robotic capabilities are truly the first of its kind and the company has combined this with deep expertise in automation and a highly effective business model which has created a leading-edge over competitors. Automata Labs accelerates human ingenuity, empowering labs, and scientists, to achieve consistent results faster, on a greater scale, and to ultimately upscale their ambitions. We are delighted to have led this financing round as Automata represented exactly the type of highly innovative company we invest in and support. We are excited for Automata’s next steps, both within the life sciences industry, and beyond."
— Jess McCreadie, Principal, Healthtech